DR BRIAN SALMONS, PHD
Dr Brian Salmons received his Ph.D. in London in 1984. After holding research positions in the U.S.A., Switzerland, and at the Ludwig Maximilian University, Munich, Germany, he became the Scientific Director of the biotech/vaccine company, Bavarian Nordic, and was involved in taking the company to IPO.
In 2002, he co-founded the Biotech company, Austrianova, a spin out of the Veterinary Medicine University in Vienna, and was instrumental in obtaining orphan drug status from the European Medicines Agency for its lead cell encapsulation product. In 2007, Dr Salmons co-founded and became the CEO of Austrianova Singapore Pte Ltd, an independent company established in Singapore to further develop the encapsulation technology as products for a variety of indications such as various forms of cancer, diabetes, neurodegenerative, cardiovascular and infectious diseases. In 2013, he also co-founded Austrianova Thailand based just outside of Bangkok as a company dedicated to the production of encapsulated cell products under GMP.
Dr Salmons is the author or co-author of over 160 peer reviewed scientific articles and publications and is a reviewer for numerous scientific/medical journals as well as the inventor of 8 patent families.